The aim of this study was to identify any associations between predictor variables, mainly risk factors and dental implant outcome performed by residents in Implantology. Dental records were reviewed from January 1, 2018, to December 31, 2020. The inclusion criteria was all implant surgery made using Intraoss brand. Data collected from the patients’ medical charts included:  implant loss, gender, diabetes, smoking, continuous use of medication, type of implant connection system, implant position (maxilla or mandible), previous bone grafting and type of prosthetic provisioning (temporary prosthesis, immediate prosthesis or permanent prosthesis). It was evaluated the cumulative survival rate of 1,164 dental implants made by residents attending an implantology residency in a university setting. One thousand forty-eight dental implants were placed on 471 patients seen by residents. The cumulative survival rate was 2.5%. Furthemore, the association of implant losses to the variables tested using the chi-square and G tests showed no statistically significant association. Based on Kaplan-Meier curve analysis, with a 95% confidence interval up to 52 months of implant placement, it revealed that the overall survival rate was 90.5%. Therefore, this study showed high survival rates of implants installed by residents of implantology at Faculdade São Leopoldo Mandic using Intraoss implants. The implant failure was not correlated with any of the variables tested.

The company Intraoss financed the research and awarded a Scientific Scholarship to M.K.

The company Intraoss financed the research and awarded a Scientific Scholarship to M.K.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The research project was approved by the Research Ethics Committee of Faculdade São Leopoldo Mandic, registration number # 49980221.7.0000.5374. All patients included in this study provided informed consent prior to implant treatment.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data are available from the São Leopoldo Mandic Institutional Data Access (contact via samanta.capeletto@slmandic.edu.br)